Erratum
Following publication of this article [1], it was noticed that the Clinical Trial Number in the last paragraph of the conclusions section was incorrectly listed as NCT02155647. The correct Clinical Trials Number is NCT02488759.
Reference
Walocko FM, Scheier BY, Harms PW, Fecher LA, Lao CD. Metastatic Merkel cell carcinoma response to nivolumab. J Immunother Cancer. 2016;4:79. doi:10.1186/s40425-016-0186-1.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1186/s40425-016-0186-1.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Walocko, F.M., Scheier, B.Y., Harms, P.W. et al. Erratum to: Metastatic Merkel cell carcinoma response to nivolumab. j. immunotherapy cancer 5, 27 (2017). https://doi.org/10.1186/s40425-017-0221-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s40425-017-0221-x